Veterinary pharmacy pushes toward formal specialty recognition

Veterinary pharmacy is at an inflection point. The question raised in Clinician’s Brief, whether veterinary pharmacy should become a specialty, now sits inside a real credentialing effort: the Board of Pharmacy Specialties, or BPS, began evaluating veterinary pharmacy through a formal job analysis process in July 2024, and professional groups spent 2025 building support for a petition seeking official recognition. (prnewswire.com)

The backdrop is a field that has grown faster than its formal infrastructure. Veterinary hospitals, compounding pharmacies, telepharmacy operations, and some academic centers increasingly rely on pharmacists with animal-specific expertise, but veterinary pharmacy has remained a niche practice area without broad specialty recognition from BPS. At the same time, AVMA’s specialist framework is centered on veterinarians, not pharmacists, which means veterinary teams have had fewer widely recognized ways to signal advanced pharmacy expertise inside animal health practice. AVMA guidance also reserves the term “specialist” for veterinarians certified through AVMA-recognized specialty pathways or comparable veterinary specialty systems, underscoring why pharmacy-side credentialing has developed on a separate track. (avma.org)

That separate track has become more organized in the past few years. The International College of Veterinary Pharmacy, an affiliate of the Society of Veterinary Hospital Pharmacists, was incorporated in 2022 and says it is the only organization currently offering pharmacists board certification in veterinary pharmacy, using the Diplomate of the International College of Veterinary Pharmacy, or DICVP, credential. It also oversees PGY1 veterinary pharmacy residency accreditation guidelines, suggesting the profession is trying to build the training and assessment structures that specialty recognition bodies typically expect. (svhp.org)

The biggest external milestone came when BPS announced a veterinary pharmacy job analysis panel in July 2024. According to BPS, the panel’s role was to define the scope of practice, identify core tasks and competencies, and evaluate whether specialty certification was feasible. BPS said that if the findings supported the field, it would issue a profession-wide call for a petition to formally recognize veterinary pharmacy and begin developing a certification program. By September 2025, ACVP, ICVP, SVHP, and the BPS Veterinary Pharmacy Practice Job Analysis Task Force said they had partnered to develop and submit that petition, while also soliciting survey responses to demonstrate profession-wide support. (prnewswire.com)

Industry and expert commentary around the effort has focused on practical gaps. Pharmacy Times reported this month that BPS is considering veterinary pharmacy for specialty certification, framing the field around disease prevention, treatment, One Health collaboration, and public health. A recent dvm360 commentary argued that most pharmacists receive little or no formal training in veterinary pharmacy during standard pharmacy education, and cited survey findings that veterinarians see pharmacists’ limited knowledge of veterinary medications as a leading barrier to collaboration. That aligns with the central argument from advocates: this isn’t just about professional recognition, but about building consistent competency in species-appropriate medication use. Clinician’s Brief’s recent “Veterinary Breakroom” discussions point to the same broader trend in practice: veterinary teams are being asked to manage more complex therapeutic decisions, faster-evolving drug categories, and more system-level public health responsibilities than many traditional training pathways were built for. (pharmacytimes.com)

Those Clinician’s Brief conversations help explain why the specialty push is resonating now. In one recent episode, hosts discussed a global Nature Communications analysis that mapped travel time to veterinary care using data from roughly 300,000 practices across 115 countries, emphasizing that access to veterinarians is not just a convenience issue but one tied to zoonotic disease control, food security, and animal welfare. In another, they highlighted AVMA debt data and the long-term impact of debt-to-income ratios on new graduates, a reminder that workforce supply and distribution pressures are shaping what kinds of support systems practices may need. In that context, better-defined pharmacy expertise is being discussed not as a siloed credentialing exercise, but as part of a larger effort to strengthen veterinary care capacity and public health infrastructure.

Clinician’s Brief also recently spotlighted how quickly therapeutics are changing. Its discussion of monoclonal antibodies noted that locivetmab, introduced in 2016, helped open the door to a fast-growing category that now includes dermatology and pain products such as Librela and Solensia, with additional expansion underway. The practical question raised there, how clinicians keep up with an exponential curve of new products and evidence, mirrors one of the strongest arguments for specialty pharmacy training. The same is true for antimicrobial stewardship: another Breakroom episode reviewed “wait-and-see prescriptions,” or WASPs, a delayed-prescribing approach used in human medicine that reduced antibiotic use by up to 60% in a pediatric otitis media study without worsening outcomes. Veterinary medicine is not identical, but the example underscores the kind of prescribing strategy, client communication, and stewardship judgment that advocates say specialized veterinary pharmacy training could help support.

Why it matters: For veterinary professionals, specialty recognition in veterinary pharmacy could have downstream effects on patient safety, prescribing confidence, and hospital operations. In practice, medication issues in animal care are often more complex than simple dose conversion. Species differences, off-label use, compounding constraints, toxic excipients, antimicrobial stewardship, and supply substitutions can all create risk points. A more standardized specialty pathway could make it easier for referral centers, teaching hospitals, and larger general practices to identify pharmacists with advanced veterinary competence, while also giving veterinarians more confidence in collaborative prescribing and dispensing workflows. As newer therapies such as monoclonal antibodies become more common, and as stewardship expectations rise, those competencies may become more valuable rather than less. (vetmeds.org)

There’s also a workforce and visibility angle. AVMA reporting has highlighted veterinary pharmacists working inside specialty and referral settings, but those roles are still not widely distributed across practice types. If BPS recognition moves forward, it could help legitimize veterinary pharmacy as a clearer career path, encourage more residency development, and support broader integration of pharmacists into veterinary teams. That may be especially relevant as hospitals manage increasingly complex therapeutics, including compounded medications, antimicrobials, advanced biologics, and the operational strain that comes with uneven access to veterinary care and a financially pressured clinician pipeline. (avma.org)

What to watch: The next key step is whether BPS formally advances the petition into specialty recognition and certification development. If that happens, veterinary pharmacy would move from an emerging niche with internal credentials to a more standardized specialty pathway, likely setting off new activity in residency training, employer demand, and interprofessional care models over the next one to two years. It will also be worth watching whether the conversation expands beyond certification alone to include how veterinary pharmacists fit into broader access, workforce, and public health planning, themes that Clinician’s Brief has increasingly linked together across its recent coverage. That timeline is an inference based on the sequence BPS described and the coalition’s 2025-2026 advocacy activity. (prnewswire.com)